期刊
CLINICAL CHEMISTRY
卷 68, 期 3, 页码 450-460出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/clinchem/hvab202
关键词
proteomics; plasma; dried blood; depletion; mass spectrometry
资金
- National Institute of Health [U01 NS115658-01]
- Erika J. Glazer COVID-19 Fund
This study developed standardized workflows for detecting circulating protein biomarkers in different blood matrices, achieving reproducible and quantifiable analysis by optimizing sample preparation and mass spectrometry. The workflows allowed for sensitive high-throughput or deeper profiling analysis, with reliable results across different biofluids. By describing the observable, reliable, reproducible, and quantifiable proteomes for each biofluid and workflow, the researchers aim to simplify discovery approaches and facilitate the translation of candidate markers into clinical use.
Background Accurate discovery assay workflows are critical for identifying authentic circulating protein biomarkers in diverse blood matrices. Maximizing the commonalities in the proteomic workflows between different biofluids simplifies the approach and increases the likelihood for reproducibility. We developed a workflow that can accommodate 3 blood-based proteomes: naive plasma, depleted plasma and dried blood. Methods Optimal conditions for sample preparation and data independent acquisition-mass spectrometry analysis were established in plasma then automated for depleted plasma and dried blood. The mass spectrometry workflow was modified to facilitate sensitive high-throughput analysis or deeper profiling with mid-throughput analysis. Analytical performance was evaluated by the linear response of peptides and proteins to a 6- or 7-point dilution curve and the reproducibility of the relative peptide and protein intensity for 5 digestion replicates per day on 3 different days for each biofluid. Results Using the high-throughput workflow, 74% (plasma), 93% (depleted), and 87% (dried blood) displayed an inter-day CV <30%. The mid-throughput workflow had 67% (plasma), 90% (depleted), and 78% (dried blood) of peptides display an inter-day CV <30%. Lower limits of detection and quantification were determined for peptides and proteins observed in each biofluid and workflow. Based on each protein and peptide's analytical performance, we could describe the observable, reliable, reproducible, and quantifiable proteomes for each biofluid and workflow. Conclusion The standardized workflows established here allows for reproducible and quantifiable detection of proteins covering a broad dynamic range. We envisage that implementation of this standard workflow should simplify discovery approaches and facilitate the translation of candidate markers into clinical use.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据